Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma

Chris Benz, Michael Choti, Lee Newcomer, Ed Cadman

Research output: Contribution to journalArticle

Abstract

Cultures of human colon carcinoma, HCT-8, were treated with millimolar concentrations of thymidine by different schedules designed to cytokinetically and biochemically modulate methotrexate (MTX) and 5-fluorouracil (FUra) toxicity. Thymidine (dThd)-synchronized HCT-8 cells monitored by flow cytofluorometry showed increased sensitivity to MTX and synergistic cytotoxicity to the combination MTX-FUra. FUra toxicity in synchronized cells showed no significant phase specificity overall, but a pattern of relative G2/M resistance was correlated with decreased intracellular FUra accumulation, incorporation into RNA, and formation of FdUMP. In asynchronous cultures dThd reduced MTX toxicity when given within the first 12 h of a 24-h MTX exposure, and also appeared to reduce the MTX-induced synergistic enhancement of FUra toxicity. When dThd was administered with FUra alone in asynchronous cultures, progressive, and synergistic enhancement of FUra toxicity was observed only after 6 h dThd pretreatment. Unlike MTX-FUra synergy, this schedule-dependent synergism between dThd and FUra did not correlate with intracellular FUra accumulation or specific incorporation into total cellular RNA. These results suggest that less well studied mechanisms of dThd modulation, other than enhanced deoxynucleotide formation or total RNA incorporation, may biochemically enhance FUra toxicity in HCT-8 cells.

Original languageEnglish (US)
Pages (from-to)104-110
Number of pages7
JournalCancer Chemotherapy and Pharmacology
Volume12
Issue number2
DOIs
StatePublished - Feb 1984
Externally publishedYes

Fingerprint

Methotrexate
Fluorouracil
Thymidine
Toxicity
Colon
Carcinoma
RNA
Appointments and Schedules
Fluorodeoxyuridylate
Cytotoxicity
Flow Cytometry
Modulation

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. / Benz, Chris; Choti, Michael; Newcomer, Lee; Cadman, Ed.

In: Cancer Chemotherapy and Pharmacology, Vol. 12, No. 2, 02.1984, p. 104-110.

Research output: Contribution to journalArticle

Benz, Chris ; Choti, Michael ; Newcomer, Lee ; Cadman, Ed. / Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. In: Cancer Chemotherapy and Pharmacology. 1984 ; Vol. 12, No. 2. pp. 104-110.
@article{4e3b4574c4024119a76f38ee23c95854,
title = "Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma",
abstract = "Cultures of human colon carcinoma, HCT-8, were treated with millimolar concentrations of thymidine by different schedules designed to cytokinetically and biochemically modulate methotrexate (MTX) and 5-fluorouracil (FUra) toxicity. Thymidine (dThd)-synchronized HCT-8 cells monitored by flow cytofluorometry showed increased sensitivity to MTX and synergistic cytotoxicity to the combination MTX-FUra. FUra toxicity in synchronized cells showed no significant phase specificity overall, but a pattern of relative G2/M resistance was correlated with decreased intracellular FUra accumulation, incorporation into RNA, and formation of FdUMP. In asynchronous cultures dThd reduced MTX toxicity when given within the first 12 h of a 24-h MTX exposure, and also appeared to reduce the MTX-induced synergistic enhancement of FUra toxicity. When dThd was administered with FUra alone in asynchronous cultures, progressive, and synergistic enhancement of FUra toxicity was observed only after 6 h dThd pretreatment. Unlike MTX-FUra synergy, this schedule-dependent synergism between dThd and FUra did not correlate with intracellular FUra accumulation or specific incorporation into total cellular RNA. These results suggest that less well studied mechanisms of dThd modulation, other than enhanced deoxynucleotide formation or total RNA incorporation, may biochemically enhance FUra toxicity in HCT-8 cells.",
author = "Chris Benz and Michael Choti and Lee Newcomer and Ed Cadman",
year = "1984",
month = "2",
doi = "10.1007/BF00254600",
language = "English (US)",
volume = "12",
pages = "104--110",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma

AU - Benz, Chris

AU - Choti, Michael

AU - Newcomer, Lee

AU - Cadman, Ed

PY - 1984/2

Y1 - 1984/2

N2 - Cultures of human colon carcinoma, HCT-8, were treated with millimolar concentrations of thymidine by different schedules designed to cytokinetically and biochemically modulate methotrexate (MTX) and 5-fluorouracil (FUra) toxicity. Thymidine (dThd)-synchronized HCT-8 cells monitored by flow cytofluorometry showed increased sensitivity to MTX and synergistic cytotoxicity to the combination MTX-FUra. FUra toxicity in synchronized cells showed no significant phase specificity overall, but a pattern of relative G2/M resistance was correlated with decreased intracellular FUra accumulation, incorporation into RNA, and formation of FdUMP. In asynchronous cultures dThd reduced MTX toxicity when given within the first 12 h of a 24-h MTX exposure, and also appeared to reduce the MTX-induced synergistic enhancement of FUra toxicity. When dThd was administered with FUra alone in asynchronous cultures, progressive, and synergistic enhancement of FUra toxicity was observed only after 6 h dThd pretreatment. Unlike MTX-FUra synergy, this schedule-dependent synergism between dThd and FUra did not correlate with intracellular FUra accumulation or specific incorporation into total cellular RNA. These results suggest that less well studied mechanisms of dThd modulation, other than enhanced deoxynucleotide formation or total RNA incorporation, may biochemically enhance FUra toxicity in HCT-8 cells.

AB - Cultures of human colon carcinoma, HCT-8, were treated with millimolar concentrations of thymidine by different schedules designed to cytokinetically and biochemically modulate methotrexate (MTX) and 5-fluorouracil (FUra) toxicity. Thymidine (dThd)-synchronized HCT-8 cells monitored by flow cytofluorometry showed increased sensitivity to MTX and synergistic cytotoxicity to the combination MTX-FUra. FUra toxicity in synchronized cells showed no significant phase specificity overall, but a pattern of relative G2/M resistance was correlated with decreased intracellular FUra accumulation, incorporation into RNA, and formation of FdUMP. In asynchronous cultures dThd reduced MTX toxicity when given within the first 12 h of a 24-h MTX exposure, and also appeared to reduce the MTX-induced synergistic enhancement of FUra toxicity. When dThd was administered with FUra alone in asynchronous cultures, progressive, and synergistic enhancement of FUra toxicity was observed only after 6 h dThd pretreatment. Unlike MTX-FUra synergy, this schedule-dependent synergism between dThd and FUra did not correlate with intracellular FUra accumulation or specific incorporation into total cellular RNA. These results suggest that less well studied mechanisms of dThd modulation, other than enhanced deoxynucleotide formation or total RNA incorporation, may biochemically enhance FUra toxicity in HCT-8 cells.

UR - http://www.scopus.com/inward/record.url?scp=0021360793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021360793&partnerID=8YFLogxK

U2 - 10.1007/BF00254600

DO - 10.1007/BF00254600

M3 - Article

C2 - 6199130

AN - SCOPUS:0021360793

VL - 12

SP - 104

EP - 110

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 2

ER -